​

Ensysce Biosciences (ENSC) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Ensysce Biosciences Revenue Highlights

Latest Revenue (Y)

$2.23M

0

Ensysce Biosciences Revenue by Period

Ensysce Biosciences Revenue by Year

DateRevenueChange
2023-12-31$2.23M-11.61%
2022-12-31$2.52M-28.54%
2021-12-31$3.53M-10.18%
2020-12-31$3.93M122.86%
2019-12-31$1.76M100.00%
2018-12-31--

Ensysce Biosciences generated $2.23M in revenue during NA 2023, up -11.61% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Ensysce Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30$181.80K-40.54%
2024-03-31$305.72K-40.64%
2023-12-31$515.03K18.29%
2023-09-30$435.38K-11.23%
2023-06-30$490.47K-37.89%
2023-03-31$789.63K-44.91%
2022-12-31$1.43M413.14%
2022-09-30$279.35K34.65%
2022-06-30$207.47K-65.60%
2022-03-31$603.10K-63.12%
2021-12-31$1.64M36.18%
2021-09-30$1.20M170.14%
2021-06-30$444.52K77.40%
2021-03-31$250.58K-39.84%
2020-12-31$416.49K-49.68%
2020-09-30$827.64K-54.64%
2020-06-30$1.82M111.58%
2020-03-31$862.40K100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Ensysce Biosciences generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Ensysce Biosciences Revenue Breakdown

Ensysce Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
M P A R-$2.01M

Quarterly Revenue by Product

Product/ServiceJun 23Mar 23Dec 22Sep 22Jun 22
MPAR$437.26K$481.28K---
M P A R--$1.30M--
OUD---$73.06K$207.47K

Ensysce Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: MPAR (100.00%).

Ensysce Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ENSCEnsysce Biosciences$2.23M-
BDRXBiodexa Pharmaceuticals$381.00K$41.50K
SONNSonnet BioTherapeutics$147.81K-
VRAXVirax Biolabs Group$8.56K$76.50K
ZURAZura Bio--
REVBRevelation Biosciences--
ATNF180 Life Sciences--
PHIOPhio Pharmaceuticals--
ALLRAllarity Therapeutics--
QNRXQuoin Pharmaceuticals--
KPRXKiora Pharmaceuticals--
CDIOCardio Diagnostics-$6.58K

ENSC Revenue FAQ

What is Ensysce Biosciences’s yearly revenue?

Ensysce Biosciences's yearly revenue for 2023 was $2.23M, representing a decrease of -11.61% compared to 2022. The company's yearly revenue for 2022 was $2.52M, representing a decrease of -28.54% compared to 2021. ENSC's yearly revenue for 2021 was $3.53M, representing a decrease of -10.18% compared to 2020.

What is Ensysce Biosciences’s quarterly revenue?

Ensysce Biosciences's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $181.8K, a -40.54% decrease from the previous quarter (Q1 2024), and a -62.93% decrease year-over-year (Q2 2023). ENSC's quarterly revenue for Q1 2024 was $305.72K, a -40.64% decrease from the previous quarter (Q4 2023), and a -61.28% decrease year-over-year (Q1 2023).

What is Ensysce Biosciences’s revenue growth rate?

Ensysce Biosciences's revenue growth rate for the last 3 years (2021-2023) was -36.83%, and for the last 5 years (2019-2023) was 26.45%.